Pocketing $3.7M, Eureka Touts Informatics as Differentiator in Sequencing Services, Microorganism Detection

Eureka Genomics has a two-pronged business model that involves sequencing services and internal discovery projects to identify novel disease-associated microorganisms. Underlying this hybrid model is a portfolio of proprietary bioinformatics tools that the company licensed in 2006 from the University of Houston.

Full-text access for premium subscribers only. Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.